The Asia Pacific DNA vaccine market was estimated to be worth $XX million in 2017. The market is predicted to grow at the highest CAGR of 42.65% over the forecast period of 2018-2026, generating $XX million by its end.The market in these regions is segmented on the basis of technology, application, and type. The applications for veterinary diseases is rapidly gaining momentum in this region. Factors like growing population with unmet medical needs, increasing awareness regarding the advantages of these vaccines and the high disposable income within the populace are primarily responsible for driving the market growth.

ASIA PACIFIC DNA VACCINES MARKET FORECAST 2018-2026

Asia Pacific DNA Vaccine Market by Type (Animal DNA Vaccine, Human DNA Vaccine) by Application (Human Disease, Veterinary Disease) by Technology (Plasmid DNA Vaccines, Plasmid DNA Delivery) by Geography

Request free sample

The Asia Pacific DNA vaccine market was estimated to be worth $XX million in 2017. The market is predicted to grow at the highest CAGR of 42.65% over the forecast period of 2018-2026, generating $XX million by its end.

Asia-Pacific DNA vaccine market

To learn more about this report, request a free sample copy

China, India, Japan, Australia and the rest of Asia-Pacific are the countries analyzed for this market. The market in these regions is segmented on the basis of technology, application, and type. The applications for veterinary diseases is rapidly gaining momentum in this region. Factors like growing population with unmet medical needs, increasing awareness regarding the advantages of these vaccines and the high disposable income within the populace are primarily responsible for driving the market growth. The China DNA vaccine market is expected to reign in this region in terms of revenue as well as CAGR growth.

Some of the major players in DNA vaccine market are Glaxosmithkline Inc, Merck & Co, Sanofi, Novartis Ag, Astellas Pharma Inc, Xenetic Biosciences Inc, Dendreon Corporation, Madison Vaccines Incorporated (MVI), Eli Lilly And Company, and Zoetis Inc.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
    4. MARKET DETERMINANTS
      • DRIVERS
        • DNA VACCINES SHOW GREAT PROMISE IN CHECKING THE RISING PREVALENCE OF DISEASES
        • THIRD GENERATION VACCINATION IS SEEING A SURGE IN INVESTMENT
        • INCREASING ADOPTION OF DNA VACCINES FOR ANIMAL HEALTHCARE
      • RESTRAINTS
        • LENGTHY REGULATORY PROCESS
        • POOR PATENT PROTECTION IN SOME COUNTRIES
      • OPPORTUNITIES
        • TRANSFORMING HEALTHCARE LANDSCAPE
        • NEW DEVELOPMENTS IN BIOTECHNOLOGIES AND NANOTECHNOLOGIES
        • STABLE VACCINES MAKE IT ATTRACTIVE TO STORE AND TRANSPORT
      • CHALLENGES
        • VACCINES FOR HUMAN USAGE STILL UNDER CLINIC TRAIL
    1. MARKET SEGMENTATION
      • MARKET BY TYPE 2018-2026
        • ANIMAL DNA VACCINE
        • HUMAN DNA VACCINE
      • MARKET BY APPLICATION 2018-2026
        • HUMAN DISEASE
        • VETERINARY DISEASE
      • MARKET BY TECHNOLOGY 2018-2026
        • PLASMID DNA VACCINES
        • PLASMID DNA DELIVERY
    1. KEY ANALYTICS
      • PORTER’S FIVE FORCE MODEL
        • THREAT OF NEW ENTRANTS
        • THREATS OF SUBSTITUTE PRODUCT
        • BARGAINING POWER OF BUYER
        • BARGAINING POWER OF SUPPLIER
        • INTENSITY OF COMPETITIVE RIVALRY
      • KEY BUYING CRITERIA
        • EFFICACY
        • COST-EFFECTIVENESS
        • STABILITY
      • KEY MARKET PLAYERS
        • VICAL INCORPORATED
        • SANOFI
        • MERCK AND CORP
        • GSK
      • OPPORTUNITY MATRIX
      • VALUE CHAIN ANALYSIS
        • R&D
        • MANUFACTURING
        • RAW MATERIALS
        • MARKETING, DISTRIBUTION & END USER
      • LEGAL, POLICY AND REGULATORY FRAMEWORK
    2. GEOGRAPHICAL ANALYSIS
      • ASIA PACIFIC
        • INDIA
        • CHINA
        • JAPAN
        • AUSTRALIA
        • REST OF ASIA PACIFIC
    1. COMPETITIVE LANDSCAPE
      • STRATEGIC INITIATIVES
        • ACQUISITION
        • PARTNERSHIP
        • COLLABORATION
        • INNOVATION
        • DISINVESTMENT
        • EXPANSION
    1. COMPANY PROFILE
      • MARKET SHARE
      • ASTELLAS PHARMA INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • DENDREON CORPORATION (ACQUIRED BY SANPOWER GROUP)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • ELI LILLY AND COMPANY
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • EUROGENTEC S.A
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • GLAXOSMITHKLINE INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • INOVIO PHARMACEUTICALS, INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • MADISON VACCINES INCORPORATED (MVI)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • MERIAL LIMITED (ACQUIRED BY BOEHRINGER INGELHEIM)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • MERCK & CO.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • NOVARTIS AG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • SANOFI
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • VGXI
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • VICAL INCORPORATED
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • XENETIC BIOSCIENCES INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATES
      • ZOETIS INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATES

     

    LIST OF TABLES

    TABLE 1                 ASIA PACIFIC DNA VACCINE MARKET 2018-2026 ($ MILLION)

    TABLE 2                 INTERVENTIONS AND PHASE OF CERTAIN DISEASE/CONDITIONS

    TABLE 3                 APPROACHES BEING TESTED TO ENHANCE THE LOW IMMUNOGENICITY

    TABLE 4                 CLINICAL TRIALS OF THE HUMANS INVOLVING DNA VACCINES

    TABLE 5                 TEMPERATURE REQUIREMENTS IN PRESERVATION FOR VARIOUS VACCINES

    TABLE 6                 ASIA PACIFIC DNA VACCINE MARKET BY TYPE 2018-2026 ($ MILLION)

    TABLE 7                 ASIA PACIFIC DNA VACCINE MARKET IN ANIMAL DNA VACCINE 2018-2026($MILLION)

    TABLE 8                 ASIA PACIFIC DNA VACCINE MARKET IN HUMAN DNA VACCINE 2018-2026

    TABLE 9                 ASIA PACIFIC DNA VACCINE MARKET BY APPLICATION 2018-2026 ($ MILLION)

    TABLE 10     ASIA PACIFIC DNA VACCINE MARKET IN HUMAN DISEASES APPLICATION 2018-2026 ($MILLION)

    TABLE 11     ASIA PACIFIC DNA VACCINE MARKET IN VETERINARY APPLICATION 2018-2026

    TABLE 12     ASIA PACIFIC DNA VACCINE MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)

    TABLE 13     ASIA PACIFIC DNA VACCINE MARKET IN PLASMID DNA VACCINES TECHNOLOGY 2018-2026

    TABLE 14     ASIA PACIFIC DNA VACCINE MARKET IN PLASMID DNA DELIVERY TECHNOLOGY 2018-2026

    TABLE 15     REGULATIONS TO BE FOLLOWED BEFORE COMMERCIALIZATION

    LIST OF FIGURES

    FIGURE 1     ASIA PACIFIC DNA VACCINE MARKET 2018-2026 ($ MILLION)

    FIGURE 2     ASIA PACIFIC DNA VACCINE MARKET IN VETERINARY DISEASES 2018-2026 ($ MILLION)

    FIGURE 3     SHARE OF TRIALS BY VACCINE TARGET IN 2016

    FIGURE 4     SEGMENT OF CLINICAL TRIALS OF DNA VACCINE BY CANCER MARKS IN 2016

    FIGURE 5     CLINICAL TRIALS OF GENE THERAPY

    FIGURE 6     ASIA PACIFIC DNA VACCINE MARKET SHARE BY TYPE 2017 & 2026 (%)

    FIGURE 7     ASIA PACIFIC DNA VACCINES MARKET IN ANIMAL DNA VACCINES 2018-2026 ($ MILLION)

    FIGURE 8     ASIA PACIFIC DNA VACCINE MARKET IN HUMAN DNA VACCINES 2018-2026($ MILLION)

    FIGURE 9     ASIA PACIFIC DNA VACCINE MARKET SHARE BY APPLICATION 2017 & 2026(%)

    FIGURE 10   ASIA PACIFIC DNA VACCINES MARKET IN HUMAN DISEASES 2018-2026 ($ MILLION)

    FIGURE 11   ASIA PACIFIC DNA VACCINES MARKET IN VETERINARY APPLICATION 2018-2026 ($ MILLION)

    FIGURE 12   ASIA PACIFIC DNA VACCINES MARKET IN PLASMID DNA VACCINES TECHNOLOGY 2018-2026 ($ MILLION)

    FIGURE 13   ASIA PACIFIC DNA VACCINES MARKET IN PLASMID DNA DELIVERY TECHNOLOGY 2018-2026 ($ MILLION)

    FIGURE 14   VALUE CHAIN ANALYSES FOR DNA VACCINE INDUSTRY

    FIGURE 15   INDIA DNA VACCINE MARKET 2018-2026 ($ MILLION)

    FIGURE 16   CHINA DNA VACCINE MARKET 2018-2026 ($ MILLION)

    FIGURE 17   JAPAN DNA VACCINE MARKET 2018-2026 ($ MILLION)

    FIGURE 18   AUSTRALIA DNA VACCINE MARKET 2018-2026 ($ MILLION)

    FIGURE 19   REST OF ASIA PACIFIC DNA VACCINE MARKET 2018-2026 ($ MILLION)

    FIGURE 20   MARKET SHARES OF TOP FIVE COMPANIES FOR DNA VACCINES MARKET IN 2017

    1. GEOGRAPHICAL ANALYSIS
      • ASIA PACIFIC
        • INDIA
        • CHINA
        • JAPAN
        • AUSTRALIA
        • REST OF ASIA PACIFIC
    1. MARKET SEGMENTATION
      • MARKET BY TYPE 2018-2026
        • ANIMAL DNA VACCINE
        • HUMAN DNA VACCINE
      • MARKET BY APPLICATION 2018-2026
        • HUMAN DISEASE
        • VETERINARY DISEASE
      • MARKET BY TECHNOLOGY 2018-2026
        • PLASMID DNA VACCINES
        • PLASMID DNA DELIVERY

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type